ES2178639T3 - Solucion estable de aminoacidos altamente concentrada. - Google Patents

Solucion estable de aminoacidos altamente concentrada.

Info

Publication number
ES2178639T3
ES2178639T3 ES93101786T ES93101786T ES2178639T3 ES 2178639 T3 ES2178639 T3 ES 2178639T3 ES 93101786 T ES93101786 T ES 93101786T ES 93101786 T ES93101786 T ES 93101786T ES 2178639 T3 ES2178639 T3 ES 2178639T3
Authority
ES
Spain
Prior art keywords
amino acid
amino acids
highly concentrated
stable solution
acid solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93101786T
Other languages
English (en)
Other versions
ES2178639T5 (es
Inventor
Douglas Giles Johnson
Josef Karl Ludwig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25318094&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2178639(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter International Inc filed Critical Baxter International Inc
Publication of ES2178639T3 publication Critical patent/ES2178639T3/es
Application granted granted Critical
Publication of ES2178639T5 publication Critical patent/ES2178639T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCION SUMINISTRA UNA SOLUCION DE AMINOACIDO ALTAMENTE CONCENTRADA, NUTRICIONALMENTE UTIL. EN UNA CONFORMACION, LA FORMULACION TIENE UN AMPLIO PERFIL DE AMINOACIDOS QUE ES ALTO TANTO EN AMINOACIDOS DE CADENA RAMIFICADA COMO ALTO EN EL PORCENTAJE TOTAL DE AMINOACIDOS. ADICIONALMENTE, LA INVENCION SUMINISTRA UN METODO PARA SELECCIONAR EL PERFIL DE AMINOACIDOS PARA OBTENER UNA CONCENTRACION MAXIMA DE AMINOACIDOS. PARA ESTE EXTREMO, SE SUMINISTRA UNA SOLUCION ESTABLE DE AMINOACIDOS QUE TIENE UN EQUILIBRIO NUTRICIONALMENTE APROPIADO DE AMINOACIDOS QUE COMPRENDE UNA CONCENTRACION TOTAL DE AMINOACIDOS IGUAL O MAYOR AL 18%. EN UNA CONFORMACION, SE SUMINISTRA UNA SOLUCION DE AMINOACIDOS QUE COMPRENDE APROXIMADAMENTE ENTRE UN 18 Y UN 22% DE AMINOACIDOS DE CADENA RAMIFICADA; Y UNA CONCENTRACION TOTAL DE AMINOACIDOS IGUAL O MAYOR AL 18%.
ES93101786T 1992-03-20 1993-02-05 Solucion estable de aminoacidos altamente concentrada. Expired - Lifetime ES2178639T5 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/854,227 US5206269A (en) 1992-03-20 1992-03-20 Highly concentrated amino acid solution
US854227 1992-03-20

Publications (2)

Publication Number Publication Date
ES2178639T3 true ES2178639T3 (es) 2003-01-01
ES2178639T5 ES2178639T5 (es) 2005-09-01

Family

ID=25318094

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93101786T Expired - Lifetime ES2178639T5 (es) 1992-03-20 1993-02-05 Solucion estable de aminoacidos altamente concentrada.

Country Status (10)

Country Link
US (1) US5206269A (es)
EP (1) EP0561141B2 (es)
JP (1) JP3704625B2 (es)
AT (1) ATE219359T1 (es)
AU (1) AU664417B2 (es)
CA (1) CA2091602C (es)
DE (1) DE69332039T3 (es)
DK (1) DK0561141T4 (es)
ES (1) ES2178639T5 (es)
PT (1) PT561141E (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1062879B1 (en) * 1999-06-26 2003-08-27 B. Braun Melsungen Ag Aqueous solution for the parenteral nutrition
JP3368897B1 (ja) * 2002-01-15 2003-01-20 味の素株式会社 分岐鎖アミノ酸含有液剤の製造方法
US8148356B2 (en) * 2005-08-24 2012-04-03 Cumberland Pharmaceuticals, Inc. Acetylcysteine composition and uses therefor
WO2010050168A1 (ja) * 2008-10-27 2010-05-06 味の素株式会社 バリン、イソロイシン、ロイシン固溶体およびその製造方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1496254A (en) * 1975-07-28 1977-12-30 Ajinomoto Kk Nutritive infusion solution and its production
DE2946563A1 (de) * 1979-11-17 1981-05-21 B. Braun Melsungen Ag, 3508 Melsungen Aminosaeureloesung zur parenteralen infusion
WO1982003552A1 (en) * 1981-04-17 1982-10-28 Hospital Supply Corp American Improved solution for parenteral nutrition
JPS58126767A (ja) * 1982-01-22 1983-07-28 Ajinomoto Co Inc 肝臓病患者用栄養組成物
AU6777487A (en) * 1985-12-18 1987-07-15 Veech, R.L. Parenteral nutrition therapy with amino acids
US5032608A (en) * 1986-09-10 1991-07-16 Dudrick Stanley J Method and substrate composition for treating atherosclerosis
US5006559A (en) * 1988-08-31 1991-04-09 Clintec Nutrition Co. Method of use of branched-chain amino acids infusions to influence appetite
FR2643266A1 (fr) * 1989-02-17 1990-08-24 Sersem Solute d'apport d'acides amines pour alimentation parenterale
DE3916903A1 (de) * 1989-05-24 1991-02-28 Leopold Pharma Gmbh Waessrige zusammensetzung fuer die parenterale ernaehrung
US5026721A (en) * 1989-06-05 1991-06-25 Dudrick Stanley J Amino acid nutritional supplement and regimen for enhancing physical performance through sound nutrition
AT394135B (de) † 1989-06-22 1992-02-10 Leopold Pharma Gmbh Waessrige aminosaeureloesung fuer die parenterale ernaehrung
US5278190A (en) * 1989-11-30 1994-01-11 Clintec Nutrition Co. Method for improving the quality of sleep and treating sleep disorders
US5051249A (en) * 1990-01-11 1991-09-24 Jack Metcoff Method of nutritional therapy

Also Published As

Publication number Publication date
DE69332039D1 (de) 2002-07-25
DK0561141T4 (da) 2005-04-18
DE69332039T2 (de) 2003-01-30
CA2091602C (en) 2003-10-07
ATE219359T1 (de) 2002-07-15
DE69332039T3 (de) 2005-12-01
PT561141E (pt) 2002-11-29
US5206269A (en) 1993-04-27
JPH0624971A (ja) 1994-02-01
CA2091602A1 (en) 1993-09-21
DK0561141T3 (da) 2002-10-14
EP0561141A1 (en) 1993-09-22
AU664417B2 (en) 1995-11-16
JP3704625B2 (ja) 2005-10-12
EP0561141B2 (en) 2005-03-30
AU3371593A (en) 1993-09-23
EP0561141B1 (en) 2002-06-19
ES2178639T5 (es) 2005-09-01

Similar Documents

Publication Publication Date Title
CA2050786A1 (en) An antimicrobial peptide and an antimicrobial composition
RU94046295A (ru) L-аспартил-d- альфа -аминоалканоил-(s)-n-d-алкилбензиламиды, используемые в качестве искусственных подслащивающих агентов, пищевой состав, способ подслащивания пищевого состава
FI873672A (fi) Kompositioner innehaollande l-3,4-dihydroxifenylalanin.
ES2130131T3 (es) Composicion estabilizante de enzimas y su utilizacion en composiciones detergentes mejoradas que contienen enzimas estabilizadas.
NO974104L (no) Faste diacyl-organiske peroksyd-dispersjoner
EP0885881A3 (en) Sulfonylalkanoylamino hydroxyethylamino sulfamic acids useful as retroviral protease inhibitors
DK627687D0 (da) Hirudinvariant
DE69515665D1 (de) Fungizide zwei- und dreikomponentenmischungen
ES2178639T3 (es) Solucion estable de aminoacidos altamente concentrada.
DK1296675T3 (da) Sammensætninger baseret på aminosyrer, egnet til behandling af hjertesvigt
AU6707686A (en) Prostate-derived growth factor
GR3006748T3 (es)
EP0063328A3 (en) Compositions containing secretin and method for preventing the adsorption of secretin
JPS6471891A (en) Thionophosphonate
PT84694B (pt) Processo para a preparacao de composicoes cardiovasculares topicas contendo um ester de acido nitrico
ATE175075T1 (de) Naehrungsformell
IT8820978A0 (it) Composizione erbicida conselettivita' aumentata e processo per la preparazione di entrambi i componenti ingredienti attivi in un solo stadio.
KR860003012A (ko) (-)시스-1,2-에폭시프로필포스폰산과 아미노산과의 염을 함유하는 수용성 제약 조성물
SU1365394A1 (ru) Гербицидный состав